![Optimizing Recombinant Protein Production in the Escherichia coli Periplasm Alleviates Stress | Applied and Environmental Microbiology Optimizing Recombinant Protein Production in the Escherichia coli Periplasm Alleviates Stress | Applied and Environmental Microbiology](https://journals.asm.org/cms/10.1128/AEM.00270-18/asset/af474697-b8e5-4178-ada2-7aa1faff98e6/assets/graphic/permzz1000cgl068.jpeg)
Optimizing Recombinant Protein Production in the Escherichia coli Periplasm Alleviates Stress | Applied and Environmental Microbiology
![Frontiers | The Bacterial Mucosal Immunotherapy MV130 Protects Against SARS-CoV-2 Infection and Improves COVID-19 Vaccines Immunogenicity Frontiers | The Bacterial Mucosal Immunotherapy MV130 Protects Against SARS-CoV-2 Infection and Improves COVID-19 Vaccines Immunogenicity](https://www.frontiersin.org/files/Articles/748103/fimmu-12-748103-HTML/image_m/fimmu-12-748103-g001.jpg)
Frontiers | The Bacterial Mucosal Immunotherapy MV130 Protects Against SARS-CoV-2 Infection and Improves COVID-19 Vaccines Immunogenicity
![Vaccines | Free Full-Text | SARS-CoV-2 Spike Protein-Induced Interleukin 6 Signaling Is Blocked by a Plant-Produced Anti-Interleukin 6 Receptor Monoclonal Antibody Vaccines | Free Full-Text | SARS-CoV-2 Spike Protein-Induced Interleukin 6 Signaling Is Blocked by a Plant-Produced Anti-Interleukin 6 Receptor Monoclonal Antibody](https://www.mdpi.com/vaccines/vaccines-09-01365/article_deploy/html/images/vaccines-09-01365-g002.png)
Vaccines | Free Full-Text | SARS-CoV-2 Spike Protein-Induced Interleukin 6 Signaling Is Blocked by a Plant-Produced Anti-Interleukin 6 Receptor Monoclonal Antibody
![Entropy | Free Full-Text | A Time-Varying Information Measure for Tracking Dynamics of Neural Codes in a Neural Ensemble | HTML Entropy | Free Full-Text | A Time-Varying Information Measure for Tracking Dynamics of Neural Codes in a Neural Ensemble | HTML](https://www.mdpi.com/entropy/entropy-22-00880/article_deploy/html/images/entropy-22-00880-g003.png)
Entropy | Free Full-Text | A Time-Varying Information Measure for Tracking Dynamics of Neural Codes in a Neural Ensemble | HTML
![Ultrasensitive deletion detection links mitochondrial DNA replication, disease, and aging | Genome Biology | Full Text Ultrasensitive deletion detection links mitochondrial DNA replication, disease, and aging | Genome Biology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13059-020-02138-5/MediaObjects/13059_2020_2138_Fig1_HTML.png)
Ultrasensitive deletion detection links mitochondrial DNA replication, disease, and aging | Genome Biology | Full Text
![Vaccines | Free Full-Text | SARS-CoV-2 Spike Protein-Induced Interleukin 6 Signaling Is Blocked by a Plant-Produced Anti-Interleukin 6 Receptor Monoclonal Antibody Vaccines | Free Full-Text | SARS-CoV-2 Spike Protein-Induced Interleukin 6 Signaling Is Blocked by a Plant-Produced Anti-Interleukin 6 Receptor Monoclonal Antibody](https://www.mdpi.com/vaccines/vaccines-09-01365/article_deploy/html/images/vaccines-09-01365-g005.png)
Vaccines | Free Full-Text | SARS-CoV-2 Spike Protein-Induced Interleukin 6 Signaling Is Blocked by a Plant-Produced Anti-Interleukin 6 Receptor Monoclonal Antibody
![Frontiers | Virus-Like Particles: Revolutionary Platforms for Developing Vaccines Against Emerging Infectious Diseases Frontiers | Virus-Like Particles: Revolutionary Platforms for Developing Vaccines Against Emerging Infectious Diseases](https://www.frontiersin.org/files/Articles/790121/fmicb-12-790121-HTML/image_m/fmicb-12-790121-g001.jpg)
Frontiers | Virus-Like Particles: Revolutionary Platforms for Developing Vaccines Against Emerging Infectious Diseases
![Amplifying immunogenicity of prospective Covid-19 vaccines by glycoengineering the coronavirus glycan-shield to present α-gal epitopes - ScienceDirect Amplifying immunogenicity of prospective Covid-19 vaccines by glycoengineering the coronavirus glycan-shield to present α-gal epitopes - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0264410X20310732-gr2.jpg)
Amplifying immunogenicity of prospective Covid-19 vaccines by glycoengineering the coronavirus glycan-shield to present α-gal epitopes - ScienceDirect
![Vaccines | Free Full-Text | SARS-CoV-2 Spike Protein-Induced Interleukin 6 Signaling Is Blocked by a Plant-Produced Anti-Interleukin 6 Receptor Monoclonal Antibody Vaccines | Free Full-Text | SARS-CoV-2 Spike Protein-Induced Interleukin 6 Signaling Is Blocked by a Plant-Produced Anti-Interleukin 6 Receptor Monoclonal Antibody](https://www.mdpi.com/vaccines/vaccines-09-01365/article_deploy/html/images/vaccines-09-01365-g003.png)
Vaccines | Free Full-Text | SARS-CoV-2 Spike Protein-Induced Interleukin 6 Signaling Is Blocked by a Plant-Produced Anti-Interleukin 6 Receptor Monoclonal Antibody
![Amazon.com: AnNafi® Viking Helmet Vendel SCA LARP Solid Steel and Brass Helmet, Silver, Free Size | Comes with Butted Chainmail Aventail & Leather Harness | Helmet Wearable for Adult & Display| Medieval Amazon.com: AnNafi® Viking Helmet Vendel SCA LARP Solid Steel and Brass Helmet, Silver, Free Size | Comes with Butted Chainmail Aventail & Leather Harness | Helmet Wearable for Adult & Display| Medieval](https://m.media-amazon.com/images/I/81j6AFzNwVL._AC_UY1000_.jpg)
Amazon.com: AnNafi® Viking Helmet Vendel SCA LARP Solid Steel and Brass Helmet, Silver, Free Size | Comes with Butted Chainmail Aventail & Leather Harness | Helmet Wearable for Adult & Display| Medieval
![Vaccines | Free Full-Text | SARS-CoV-2 Spike Protein-Induced Interleukin 6 Signaling Is Blocked by a Plant-Produced Anti-Interleukin 6 Receptor Monoclonal Antibody Vaccines | Free Full-Text | SARS-CoV-2 Spike Protein-Induced Interleukin 6 Signaling Is Blocked by a Plant-Produced Anti-Interleukin 6 Receptor Monoclonal Antibody](https://www.mdpi.com/vaccines/vaccines-09-01365/article_deploy/html/images/vaccines-09-01365-g001.png)
Vaccines | Free Full-Text | SARS-CoV-2 Spike Protein-Induced Interleukin 6 Signaling Is Blocked by a Plant-Produced Anti-Interleukin 6 Receptor Monoclonal Antibody
![A multinational study of acute and long‐term outcomes of Type 1 galactosemia patients who carry the S135L (c.404C > T) variant of GALT - Katler - Journal of Inherited Metabolic Disease - A multinational study of acute and long‐term outcomes of Type 1 galactosemia patients who carry the S135L (c.404C > T) variant of GALT - Katler - Journal of Inherited Metabolic Disease -](https://onlinelibrary.wiley.com/cms/asset/300a5c61-97ee-43ef-98b2-9f399e1c57a6/jimd.v45.5.cover.jpg?trick=1664294532155)
A multinational study of acute and long‐term outcomes of Type 1 galactosemia patients who carry the S135L (c.404C > T) variant of GALT - Katler - Journal of Inherited Metabolic Disease -
![Rapid Identification of Synthetic Routes to Functional Metastable Phases Using X-ray Probed Laser Anneal Mapping (XPLAM) Time–Temperature Quench Maps | Chemistry of Materials Rapid Identification of Synthetic Routes to Functional Metastable Phases Using X-ray Probed Laser Anneal Mapping (XPLAM) Time–Temperature Quench Maps | Chemistry of Materials](https://pubs.acs.org/cms/10.1021/acs.chemmater.0c04926/asset/images/medium/cm0c04926_0001.gif)